Recursion · Company profile
Recursion · 美国 · AI, models, and data
Registered focus: 表型组学、自动化实验、AI药物发现. Focus is directory metadata; inspect the sources and project evidence below to assess specific capabilities.
Aliases: Recursion Pharmaceuticals、Exscientia
Public reviewed developments
Genentech 将与 Recursion 合作的首个神经科学靶点推进至联合早期发现
Wed Aug 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Recursion 官方公告，Genentech 已将双方合作的首个神经科学靶点推进至联合早期发现项目。属于研发阶段进展，不是临床试验结果。
Collaboration, licensing, and acquisition timeline
Genentech 将与 Recursion 合作的首个神经科学靶点推进至联合早期发现
Wed Aug 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Recursion 官方公告，Genentech 已将双方合作的首个神经科学靶点推进至联合早期发现项目。属于研发阶段进展，不是临床试验结果。
These are drawn from the latest 1 reviewed developments. A collaboration, model performance, experimental results, and clinical progress each require their own evidence.
Public source records
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Recursion official investor newsroom · Indexed industry source record · Source published: Wed Aug 05 2026 10:30:38 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:07:50 GMT+0000 (Coordinated Universal Time)
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program August 5, 2026 at 6:30 AM EDT PDF Version Genentech advanced the collaboration's first neurosci
Verified official and subscription sources
- Recursion official investor newsroom · Collection enabled · Last successful collection Fri Oct 09 2026 07:09:17 GMT+0000 (Coordinated Universal Time)
Source verification and ongoing collection are shown separately. Indexed source records do not automatically become reviewed events.
Reader guides: from sources to conclusions
Compare models by task and follow collaborations through evidence. Each guide includes original sources and a review date.
How should we compare virtual cells, AI models, and companies?
Compare single-cell models, structure prediction, and protein design by inputs, outputs, tasks, and validation conditions. Distinguish model papers from company capabilities.
Reader guide · updated 2026-10-08
AI drug discovery collaboration timelines: from announcements to evidence
Use real official announcements to distinguish partners, upfront payments, conditional milestones, and R&D progress, and build a traceable collaboration timeline.
Reader guide · updated 2026-10-08
How to read weekly AI drug discovery updates: companies, research, and coverage gaps
Build a weekly reading routine, distinguish announcements, papers, and clinical results, and understand this site’s weekly indexing window, denominators, and source coverage.
Reader guide · updated 2026-10-08